Top Markets
#1 bitcastle Token bitcastle Token +151.43%
#2 MarsCoin MarsCoin +70.18%
#3 Palladium Network Palladium Network +53.05%
#4 Siren Siren +28.27%
#5 edgeX edgeX +23.02%
#6 Status Status +20.93%
#7 Useless Coin Useless Coin +18.68%
#8 Bedrock Bedrock +18.28%
#9 PondCoin PondCoin +15.49%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.19%
Coin of the day
bitcastle Token bitcastle Token
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
KemPharm, Inc. KemPharm, Inc.

KemPharm, Inc.

KMPH
Peringkat dalam Saham #18406
KemPharm, Inc. operates as a specialized pharmaceutical firm focused on... KemPharm, Inc. operates as a specialized pharmaceutical firm focused on discovering and advancing proprietary prodrugs to tackle serious medical conditions across the United States. The company employs its innovative Ligand Activated Therapy (LAT) platform to create improved prodrug versions of medications already approved by the FDA, and also to develop prodrugs from existing compounds for potential applications in new disease indications. Its pipeline of investigational prodrugs strategically targets high-need areas such as attention deficit hyperactivity disorder (ADHD), stimulant use disorder, and various rare central nervous system (CNS) disorders, including idiopathic hypersomnia (IH). KP1077, KemPharm's leading experimental compound, is a prodrug of d-methylphenidate, known as serdexmethylphnidate, and is currently in Phase II clinical trials for the treatment of IH and narcolepsy. Additionally, the company is advancing KP879, a prodrug candidate designed to treat stimulant use disorder, which is undergoing Phase I clinical evaluation. KemPharm has also obtained FDA approval for AZSTARYS, a new once-daily ADHD treatment for patients aged six years and older, and for APADAZ, an immediate-release combination product containing benzhydrocodone (a prodrug of hydrocodone) and acetaminophen. The company holds collaboration and license agreements with KVK-Tech, Inc. and Commave Therapeutics SA. Founded in 2006, KemPharm, Inc. is headquartered in Celebration, Florida.
Harga Saham
$5.81
Terakhir disinkronkan: 2023-02-28
Kapitalisasi Pasar
$200.14M
Perubahan (1 hari)
-0.34%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan KemPharm, Inc. (KMPH)

Kategori

Healthcare
Riwayat harga saham KemPharm, Inc. (KMPH)
Harga penutupan tertinggi: $5.54 pada 2023-02-01

Harga penutupan terendah: $11.07 pada 2015-04-01
Riwayat harga saham KemPharm, Inc. dari 2015 hingga 2026
Performa harga saham tahunan
Tahun Performa
2023 22.80%
2022 -46.25%
2021 3,183.01%
2020 -31.88%
2019 -83.62%
2018 -39.43%
2017 8.52%
2016 -80.65%
2015 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $556.43 40.29%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 45.39%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $152.82 535.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $123.39 -8.70%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $756.41 6.58%
CH